BLK
61
-2
WHR
65
-7
COST
66
3
XYL
49
-7
BXP
60
5
ABBV
50
8
LEG
43
-7
IRM
52
2
AVY
54
-4
ETR
72
3
MSFT
57
6
MHK
50
-5
MRK
35
2
CPB
40
3
DAL
79
-4
CVX
46
8
BA
56
-2
ALL
51
3
HUM
41
-2
WM
82
2
BLK
61
-2
WHR
65
-7
COST
66
3
XYL
49
-7
BXP
60
5
ABBV
50
8
LEG
43
-7
IRM
52
2
AVY
54
-4
ETR
72
3
MSFT
57
6
MHK
50
-5
MRK
35
2
CPB
40
3
DAL
79
-4
CVX
46
8
BA
56
-2
ALL
51
3
HUM
41
-2
WM
82
2
Financhill
Back

Cartesian Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison

Sell
38

RNAC
Cartesian Therapeutics

Last Price:
17.97
Seasonality Move:
13.13%
Sell
19

NBY
NovaBay Pharmaceuticals

Last Price:
0.59
Seasonality Move:
1.46%
Sell
38
Cartesian Therapeutics (RNAC) is a Sell

Is Cartesian Therapeutics a Buy, Sell or Hold?

  • The current Cartesian Therapeutics [RNAC] share price is $18.65. The Score for RNAC is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • RNAC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.61. The Score for NBY is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

RNAC Stock Price Chart

What is Cartesian Therapeutics's stock price today?

  • The Cartesian Therapeutics share price today is $18.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAC is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.61
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.

RNAC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.59 Sell
Relative Strength Index (14 RSI): 48.94 Sell
Chaikin Money Flow: 61642 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.54 - 21.2) Sell
Bollinger Bands (100): (14.37 - 20.35) Buy

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 39.49 Sell
Chaikin Money Flow: -71560 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.63 - 0.75) Sell
Bollinger Bands (100): (0.27 - 1.35) Sell

RNAC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 17.81 Buy
20-day SMA: 18.75 Sell
50-day SMA: 19.46 Sell
200-day SMA: 19.96 Sell
8-day EMA: 18.07 Buy
20-day EMA: 18.66 Sell
50-day EMA: 18.88 Sell
200-day EMA: 20.89 Sell

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.68 Sell
20-day SMA: 0.71 Sell
50-day SMA: 0.67 Sell
200-day SMA: 2.28 Sell
8-day EMA: 0.67 Sell
20-day EMA: 0.68 Sell
50-day EMA: 0.72 Sell
200-day EMA: 5.47 Sell

Cartesian Therapeutics Earnings Growth & RNAC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.90 per share, and an increase next year of $1.70 per share.

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.

Cartesian Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):